Heart transplantation is a valid therapeutic option for anthracycline cardiomyopathy.
Dorent
R
R
Department of Thoracic and Cardiovascular Surgery, CHU Pitié Salpetriere, Paris, France.
Pavie
A
A
Nataf
P
P
Tedy
G
G
Vaissier
E
E
Ghoussoub
J J
JJ
Bors
V
V
Gandjbakhch
I
I
D000206:Actuarial Analysis; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000139:chemically induced / Q000601:surgery*; D016572:Cyclosporine / Q000627:therapeutic use; D003630:Daunorubicin / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects*; D005260:Female; D016027:Heart Transplantation / Q000276:immunology / Q000401:mortality; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D015996:Survival Rate
D004317:Doxorubicin; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D003630:Daunorubicin